Application for WHO international nonproprietary name for pharmaceutical substancesXU Li, GUO Zhong-ping257-262
Global patent layout analysis of the CDK4/6 inhibitor ribociclibDENG Yu-xiao, LIU Kui-kui, SUN Jin-rui, DUAN Chong-gang, LIN Zhi-mi, LI Dan, REN Ye-ming, FENG Guang-ling268-273
Brief introduction of the USA national drug code directory and its application in the availability of reference listed drugNIU Jian-zhao, YANG Dong-sheng, XU Ming-di274-277
Repeated dose toxicity of humanized anti-HER2 antibody-drug conjugate in cynomolgus monkeysWANG Xin, HUANG Ying, HAI Gang, QU Zhe, MIAO Yu-fa, SUN Li, JIANG Hua, LI Lu-lu, WANG Hai-bin, HUO Yan278-285
Research progress of transdermal drug delivery system of traditional Chinese medicine and the application of new formulationsPANG Xiao-chen, CHENG Rui-zhen, ZHAO Jing, LI Yue286-291
Research progress on the chemical composition, analytical method and pharmacological action of Rhizoma picrorhizaeJIN Cheng, WU Fei, ZHENG Xiao, FANG Xin, HU Jia-liang, FENG Yi292-302
Advances in clinical research of apatinib in the treatment of lung cancerFANG Zhang-lan, JIANG Tao303-307
Impact of hypoproteinemia on plasma trough concentration of voriconazole in critically ill patientsXU Bing-fa, CHEN Si-yuan, ANG Wei, LIN Xu-fang, FAN Lu-yan308-313
Quality management of drug clinical trials based on GCP pharmacyYU Wen-hui, LIANG Yan, ZHAO Xia, CUI Yi-min314-318